Holdings of iShares Global Healthcare ETF
iShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 3.6B $ including 3.6B $ in equities, 99.5 %
- Positions
- 113 in 16 countries
- Top ten
- 45.8 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 372,144 | 342.3M $ | 9.44 % |
| 2 | Johnson & Johnson | 1,131,730 | 276.6M $ | 7.63 % |
| 3 | AbbVie Inc | 829,997 | 180.5M $ | 4.98 % |
| 4 | AstraZeneca PLC | 745,465 | 145.8M $ | 4.02 % |
| 5 | Merck & Co Inc | 1,192,992 | 143.5M $ | 3.96 % |
| 6 | Novartis AG | 913,813 | 140.3M $ | 3.87 % |
| 7 | Roche Holding AG | 337,676 | 134.8M $ | 3.72 % |
| 8 | UnitedHealth Group Inc | 435,399 | 117.8M $ | 3.25 % |
| 9 | Amgen Inc | 258,827 | 91.1M $ | 2.51 % |
| 10 | Thermo Fisher Scientific Inc | 180,589 | 88.8M $ | 2.45 % |
| 11 | Abbott Laboratories | 835,802 | 85.8M $ | 2.37 % |
| 12 | Gilead Sciences Inc | 596,340 | 83.1M $ | 2.29 % |
| 13 | Intuitive Surgical Inc | 170,701 | 78.7M $ | 2.17 % |
| 14 | Pfizer Inc | 2,732,853 | 76.7M $ | 2.12 % |
| 15 | Bristol-Myers Squibb Co | 978,842 | 59.4M $ | 1.64 % |
| 16 | Danaher Corp | 302,406 | 57.3M $ | 1.58 % |
| 17 | Novo Nordisk A/S | 1,530,419 | 56M $ | 1.55 % |
| 18 | Vertex Pharmaceuticals Inc | 122,095 | 54.5M $ | 1.50 % |
| 19 | Stryker Corp | 165,557 | 54.4M $ | 1.50 % |
| 20 | GSK PLC | 1,959,178 | 54M $ | 1.49 % |
| 21 | Medtronic PLC | 616,203 | 53.4M $ | 1.47 % |
| 22 | McKesson Corp | 58,928 | 51M $ | 1.41 % |
| 23 | Sanofi SA | 515,822 | 49.8M $ | 1.37 % |
| 24 | Boston Scientific Corp | 712,828 | 44.7M $ | 1.23 % |
| 25 | CVS Health Corp | 611,490 | 43.9M $ | 1.21 % |
| 26 | Regeneron Pharmaceuticals, Inc. | 48,287 | 37.3M $ | 1.03 % |
| 27 | HCA Healthcare Inc | 75,242 | 35.6M $ | 0.98 % |
| 28 | Cigna Group/The | 126,718 | 33.8M $ | 0.93 % |
| 29 | EssilorLuxottica SA | 140,292 | 32.7M $ | 0.90 % |
| 30 | Elevance Health Inc | 105,796 | 31M $ | 0.85 % |
| 31 | Cencora Inc | 93,512 | 29.4M $ | 0.81 % |
| 32 | Takeda Pharmaceutical Co Ltd | 768,492 | 28.3M $ | 0.78 % |
| 33 | Hoya Corp | 162,800 | 28.2M $ | 0.78 % |
| 34 | Zoetis Inc | 202,898 | 24M $ | 0.66 % |
| 35 | Cardinal Health, Inc. | 113,115 | 23.9M $ | 0.66 % |
| 36 | CSL Ltd | 233,192 | 22.9M $ | 0.63 % |
| 37 | Edwards Lifesciences Corp | 278,323 | 22.3M $ | 0.62 % |
| 38 | Bayer AG | 472,204 | 21.9M $ | 0.60 % |
| 39 | Lonza Group AG | 33,764 | 21.7M $ | 0.60 % |
| 40 | Argenx SE | 29,750 | 21.6M $ | 0.60 % |
| 41 | IDEXX Laboratories Inc | 38,388 | 21.6M $ | 0.60 % |
| 42 | Becton Dickinson & Co | 136,872 | 21.5M $ | 0.59 % |
| 43 | Haleon PLC | 4,281,064 | 21.2M $ | 0.58 % |
| 44 | Alcon AG | 240,185 | 18.2M $ | 0.50 % |
| 45 | Otsuka Holdings Co Ltd | 247,900 | 17.6M $ | 0.49 % |
| 46 | UCB SA | 57,975 | 17.5M $ | 0.48 % |
| 47 | Galderma Group AG | 87,980 | 17.3M $ | 0.48 % |
| 48 | Chugai Pharmaceutical Co Ltd | 309,800 | 17.1M $ | 0.47 % |
| 49 | Sandoz Group AG | 211,490 | 16.6M $ | 0.46 % |
| 50 | Daiichi Sankyo Co Ltd | 911,600 | 16.3M $ | 0.45 % |
| 51 | ResMed Inc | 70,026 | 15.7M $ | 0.43 % |
| 52 | GE HealthCare Technologies Inc | 219,057 | 15.6M $ | 0.43 % |
| 53 | Agilent Technologies Inc | 135,946 | 15.5M $ | 0.43 % |
| 54 | Astellas Pharma Inc | 870,075 | 14.2M $ | 0.39 % |
| 55 | Waters Corp | 47,153 | 14M $ | 0.39 % |
| 56 | IQVIA Holdings Inc | 81,523 | 13.9M $ | 0.38 % |
| 57 | Biogen Inc | 70,542 | 12.9M $ | 0.36 % |
| 58 | Mettler-Toledo International Inc | 9,940 | 12.5M $ | 0.35 % |
| 59 | Dexcom Inc | 185,939 | 11.7M $ | 0.32 % |
| 60 | Labcorp Holdings Inc | 39,469 | 10.5M $ | 0.29 % |
| 61 | STERIS PLC | 47,152 | 10.4M $ | 0.29 % |
| 62 | Quest Diagnostics Inc | 53,087 | 10.4M $ | 0.29 % |
| 63 | BeOne Medicines Ltd | 459,000 | 10.3M $ | 0.28 % |
| 64 | Koninklijke Philips NV | 376,196 | 10.3M $ | 0.28 % |
| 65 | Fresenius SE & Co. KGaA | 197,412 | 10.2M $ | 0.28 % |
| 66 | Celltrion Inc | 75,531 | 10.1M $ | 0.28 % |
| 67 | Humana Inc | 57,974 | 10.1M $ | 0.28 % |
| 68 | Terumo Corp | 704,200 | 9.5M $ | 0.26 % |
| 69 | Zimmer Biomet Holdings Inc | 95,257 | 8.6M $ | 0.24 % |
| 70 | West Pharmaceutical Services Inc | 34,364 | 8.6M $ | 0.24 % |
| 71 | Shionogi & Co Ltd | 388,300 | 8.6M $ | 0.24 % |
| 72 | Moderna Inc | 167,160 | 8.5M $ | 0.23 % |
| 73 | Genmab A/S | 31,458 | 8.5M $ | 0.23 % |
| 74 | Hologic Inc | 105,269 | 8M $ | 0.22 % |
| 75 | Merck KGaA | 62,124 | 7.9M $ | 0.22 % |
| 76 | Viatris Inc | 566,606 | 7.7M $ | 0.21 % |
| 77 | Incyte Corp | 80,362 | 7.6M $ | 0.21 % |
| 78 | Centene Corp | 221,149 | 7.2M $ | 0.20 % |
| 79 | Insulet Corp | 33,371 | 7M $ | 0.19 % |
| 80 | Cooper Cos Inc/The | 94,640 | 6.8M $ | 0.19 % |
| 81 | Smith & Nephew PLC | 412,571 | 6.5M $ | 0.18 % |
| 82 | Siemens Healthineers AG | 139,012 | 5.9M $ | 0.16 % |
| 83 | Roche Holding AG | 13,956 | 5.8M $ | 0.16 % |
| 84 | Straumann Holding AG | 54,612 | 5.7M $ | 0.16 % |
| 85 | Align Technology Inc | 32,740 | 5.6M $ | 0.15 % |
| 86 | Sonova Holding AG | 23,933 | 5.5M $ | 0.15 % |
| 87 | Olympus Corp | 542,200 | 5.2M $ | 0.14 % |
| 88 | Sigma Healthcare Ltd | 2,721,744 | 5M $ | 0.14 % |
| 89 | Revvity Inc | 54,982 | 4.8M $ | 0.13 % |
| 90 | Universal Health Services Inc | 26,761 | 4.8M $ | 0.13 % |
| 91 | Solventum Corp | 69,720 | 4.6M $ | 0.13 % |
| 92 | Fresenius Medical Care AG | 98,883 | 4.5M $ | 0.12 % |
| 93 | Eisai Co Ltd | 141,200 | 4.4M $ | 0.12 % |
| 94 | Charles River Laboratories International Inc | 24,495 | 4.2M $ | 0.12 % |
| 95 | Eurofins Scientific SE | 55,257 | 4M $ | 0.11 % |
| 96 | Baxter International Inc | 239,955 | 4M $ | 0.11 % |
| 97 | QIAGEN NV | 99,405 | 4M $ | 0.11 % |
| 98 | Bio-Techne Corp | 74,212 | 3.9M $ | 0.11 % |
| 99 | Coloplast A/S | 56,784 | 3.9M $ | 0.11 % |
| 100 | Ono Pharmaceutical Co Ltd | 234,800 | 3.8M $ | 0.10 % |
Sector breakdown
- Health care 88.0 %
- Consumer staples 0.6 %
- Unattributed 11.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 70.0 %
- CHF 10.1 %
- GBP 6.3 %
- EUR 5.5 %
- JPY 4.4 %
- DKK 1.9 %
- AUD 1.0 %
- HKD 0.3 %
- KRW 0.3 %
- BRL 0.1 %
- SEK 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 70.1 %
- Switzerland 10.1 %
- United Kingdom 6.3 %
- Japan 4.4 %
- France 2.4 %
- Denmark 1.9 %
- Germany 1.5 %
- Belgium 1.1 %
- Australia 1.0 %
- Hong Kong SAR China 0.3 %
- Netherlands 0.3 %
- South Korea 0.3 %
- Other countries 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 60 | 2.5B $ | 70.14 % |
| 2 | Switzerland | 9 | 365.7M $ | 10.14 % |
| 3 | United Kingdom | 4 | 227.5M $ | 6.31 % |
| 4 | Japan | 13 | 157.3M $ | 4.36 % |
| 5 | France | 3 | 85M $ | 2.36 % |
| 6 | Denmark | 4 | 69.8M $ | 1.93 % |
| 7 | Germany | 6 | 53.4M $ | 1.48 % |
| 8 | Belgium | 2 | 39.1M $ | 1.08 % |
| 9 | Australia | 5 | 37.2M $ | 1.03 % |
| 10 | Hong Kong SAR China | 1 | 10.3M $ | 0.29 % |
| 11 | Netherlands | 1 | 10.3M $ | 0.29 % |
| 12 | South Korea | 1 | 10.1M $ | 0.28 % |
Cite this page
Titelia. "Holdings of iShares Global Healthcare ETF". https://titelia.com/en/funds/S000004372